XML 50 R40.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation (Tables)
9 Months Ended
Mar. 31, 2021
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of options Activity

The following is a summary of options activity for the nine months ended March 31, 2021:

Weighted-Average

Remaining

Aggregate

Number of

Weighted-Average

Contractual Life

Intrinsic Value

Options

Exercise Price

(in years)

(in thousands)

Outstanding as of July 1, 2020

 

1,439,630

$

31.95

 

Granted

 

281,075

 

32.03

 

Exercised

 

(45,136)

23.66

 

Forfeited

 

(1,288)

49.05

 

Expired

 

(35,050)

41.84

 

Outstanding as of March 31, 2021

 

1,639,231

 

31.99

 

6.45

$

14,246

Exercisable as of March 31, 2021

 

985,701

$

29.24

 

5.28

$

11,093

Fair Values of Stock Option Awards Estimated Weighted Average Assumptions The fair value of Adtalem’s stock option grants was estimated assuming the following weighted-average assumptions:

Fiscal Year

2021

2020

Expected life (in years)

 

6.54

 

6.51

 

Expected volatility

 

39.27

%

37.66

%

Risk-free interest rate

 

0.45

%

1.40

%

Dividend yield

 

0.00

%

0.00

%

Summary of Restricted Stock Units Activity The following is a summary of RSU activity for the nine months ended March 31, 2021:

Weighted-Average

Number of

Grant Date

RSUs

Fair Value

Outstanding as of July 1, 2020

 

767,973

$

39.42

Granted

 

564,900

 

30.62

Vested

 

(366,852)

 

34.95

Forfeited

 

(38,619)

 

38.13

Outstanding as of March 31, 2021

 

927,402

$

35.88

Total Stock-Based Compensation Expense Included in Consolidated Statement of Earnings

The following table shows total stock-based compensation expense included in the Consolidated Statements of Income (in thousands):

Three Months Ended

Nine Months Ended

March 31, 

March 31, 

2021

2020

2021

2020

Cost of educational services

$

338

$

260

$

1,076

$

1,027

Student services and administrative expense

 

3,257

 

2,521

 

10,171

 

10,301

 

3,595

 

2,781

 

11,247

 

11,328

Income tax benefit

 

(910)

 

(642)

 

(2,077)

 

(3,887)

Net stock-based compensation expense

$

2,685

$

2,139

$

9,170

$

7,441